Related Experiment Videos
Targeting cerebral arteries for gene therapy
Yoshimasa Watanabe1, Donald D Heistad
1Department of Internal Medicine, Cardiovascular Center, University of Iowa College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242, USA.
Experimental Physiology
|March 22, 2005
Summary
Gene therapy shows promise for cerebral arterial diseases by modifying gene expression. However, significant safety challenges remain before human clinical applications can be realized.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Neurology
Background:
- Gene therapy is advancing for cerebral arterial diseases, enabling gene expression modification in cerebral arteries.
- Research has identified potential targets and tested strategies in animal models of cerebrovascular disorders.
Purpose of the Study:
- To review the current status and feasibility of gene therapy for cerebral arterial diseases.
- To identify challenges and future research directions for clinical application.
Main Methods:
- Review of existing literature on cerebrovascular gene therapy.
- Analysis of animal models and preclinical studies.
- Evaluation of safety concerns and potential therapeutic targets.
Main Results:
- Gene therapy applications for cerebral arterial diseases are becoming feasible.
- Numerous strategies have been tested in animal models.
- Significant safety obstacles must be addressed for human trials.
Conclusions:
- Cerebral arterial disease gene therapy is in early stages.
- Extensive basic and preclinical research is required to develop safe and effective techniques.
- Overcoming safety issues is critical for clinical translation.